- PREVENT Cancer (NCI/NIH)
Kirnbauer (co-PI)
2016 – 2025
cGMP production, IND-enabling toxicology studies and regulatory support of experimental RG1-VLP HPV vaccine and first-in-human phase I trial
- Austrian Science Foundation (FWF I-5123-B)
Kirnbauer (PI)
5/1/2022 – 4/31/2026
A Broad-Spectrum Human Papillomavirus (HPV) Vaccine Based on a Recombinant Measles Virus Vector
- Austrian Science Foundation (FWF I-5123-B)
Kirnbauer (PI)
11/2/2022 – 10/31/2026
Phase I trial of a broad-spectrum HPV vaccine candidate RG1-VLP
- P50CA098252
Wu (PI), Role: Project 1 Co-Investigator
1/1/2021 – 12/31/2024
SPORE in cervical cancer